New constituents and antiplatelet aggregation and anti-HIV principles of Artemisia capillaris

Bioorg Med Chem. 2001 Jan;9(1):77-83. doi: 10.1016/s0968-0896(00)00225-x.

Abstract

Five new constituents including a flavonoid, artemisidin A (1), and four coumarins, artemicapins A (2), B (3), C (4) and D (5), together with 70 known compounds (6-75), have been isolated and characterized from the aerial part of Artemisia capillaris. The structures of these compounds were determined from spectral analyses and/or chemical evidence. Among them, 15 compounds (3, 6, 10, 18. 30-32, 38-41, 44, 45, 51, and 55) showed antiplatelet aggregation activity and three compounds (10, 17, and 51) demonstrated significant activity against HIV replication in H9 lymphocytic cells.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylene / analogs & derivatives*
  • Acetylene / pharmacology
  • Animals
  • Anti-HIV Agents / isolation & purification*
  • Artemisia / chemistry*
  • Blood Platelets / drug effects
  • Caffeic Acids / pharmacology
  • Coumarins / pharmacology
  • Magnetic Resonance Spectroscopy
  • Molecular Structure
  • Plants, Medicinal*
  • Platelet Aggregation Inhibitors / isolation & purification*
  • Platelet Aggregation Inhibitors / pharmacology
  • Rabbits
  • Spectrophotometry

Substances

  • Anti-HIV Agents
  • Caffeic Acids
  • Coumarins
  • Platelet Aggregation Inhibitors
  • phenylacetylene
  • Acetylene
  • caffeic acid